For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global qPCR and dPCR Instrumentation market for 2018-2023.
Real-time PCR or quantitative PCR is a well-established technology that has become the tool of choice for the rapid, sensitive quantification of nucleic acid in various biological samples. qPCR measures the accumulation of DNA during a PCR reaction. The increase in quantity of DNA at each cycle is measured by the change in intensity of a fluorescent signal. Comparison to a reference sample determines the number of original copies of template DNA in the reaction.
Digital PCR is a highly precise approach to sensitive nucleic acid detection and quantification. Each sample is partitioned into thousands of individual reactions (droplets for Droplet Digital PCR technology). Each partition is analyzed after end-point PCR cycling for the presence or absence of a fluorescent signal, and the absolute number of molecules present in the sample is calculated. dPCR does not require a standard curve for quantification.
Both quantitative PCR (qPCR) and digital PCR (dPCR) provide sensitive and specific detection, and precise quantification of nucleic acids. Both technologies have similarities, but they have differences that make one or the other the more adapted choice for specific applications.
On the basis of technology, the dPCR and qPCR market is categorized into digital PCR (dPCR) and quantitative PCR (qPCR/real-time PCR). The qPCR technology segment is expected to account for the larger share of the global dPCR and qPCR market in 2017; whereas, the dPCR segment is expected to grow at the highest CAGR during the forecast period. Factors such as ongoing technological developments in dPCR, continued expansion in distribution networks of emerging dPCR product manufacturers in global markets, and growing private funding to develop and commercialize innovative dPCR instruments are contributing to the growth of the dPCR technology segment.
On the basis of application, the dPCR and qPCR market is categorized into clinical applications, research applications, and others. The clinical applications segment is further divided into pathogen testing, oncology testing, blood screening, and other clinical applications. The clinical applications segment is expected to grow at the highest CAGR during the forecast period owing to the technological benefits offered by dPCR over qPCR and traditional PCR, growing adoption of dPCR among hospitals and diagnostic centers, increasing global burden for infectious diseases and cancer, and expansion in distribution networks of emerging dPCR product manufacturers.
Geographically, North America holds the largest market share, with about 48.68% production share and 40.77% consumption market share in 2017, followed by Europe. The strong position of North America in this market can be attributed to factors such as increase in public and private funding and growing number of research grants to support gene-based research (such as qPCR and dPCR). Asia-Pacific is projected to be the fastest-growing region in the qPCR and dPCR market owing to increasing focus of global life sciences market players on this region, burgeoning efforts to increase awareness related to gene-based disease diagnosis and treatment, growing public and private support to develop novel qPCR and dPCR technologies. Due to the significant growth opportunities offered by emerging countries, a number of players operating in the market are focusing on expanding their product distribution networks across emerging countries.
Over the next five years, LPI(LP Information) projects that qPCR and dPCR Instrumentation will register a 8.2% CAGR in terms of revenue, reach US$ 1480 million by 2023, from US$ 930 million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of qPCR and dPCR Instrumentation market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Segmentation by application:
- Clinical Use
- Research Use
This report also splits the market by region:
- - United States
- - Canada
- - Mexico
- - Brazil
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- - Germany
- - France
- - UK
- - Italy
- - Russia
- - Spain
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
- Thermo Fisher
- Analytik Jena
- RainDance Technologies
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
- To study and analyze the global qPCR and dPCR Instrumentation consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
- To understand the structure of qPCR and dPCR Instrumentation market by identifying its various subsegments.
- Focuses on the key global qPCR and dPCR Instrumentation manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the qPCR and dPCR Instrumentation with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of qPCR and dPCR Instrumentation submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.